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Abstract: The effects of diets containing 2%
and 4% calcium (Ca) on deoxycorticosteron
(DOC) salt hypertension were studied in 29
male rats weighting 210–260 g. Rats were
categorized into four groups: Group I:
control rats (6), group II: DOC hypertensive
group (n=8), group III: DOC–low Ca diet (2%
CaCl2) (8) and group IV: DOC–high Ca diet
(4% CaCl2) (n=7). During the six weeks
follow up period, indirect systolic blood
pressure (SBP) was highest in group II while
it was found to be less increased in group III
and IV. Weight increase was lowest in group
IV (P<0.005 versus 3 other groups). There
was no relationship between blood pressure
(BP) and plasma renin activity (PRA),
parathormon (PTH), angiotensin II (AII),
serum Ca, serum phosphorus, urine Ca and
final body weight. Serum Ca level was lower
in group II as compared to group III
(P<0.006). PTH was lower in group III and
IV than other groups but the differences
were statistically nonsignificant. PRA was
found supressed in group IV and group II
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Introduction
In human hypertension, Ca supplementation has been
suggested to decrease blood pressure (1, 2). Ca
supplementation is especially effective in sodium
volume–dependent hypertension in various experimental
models (3, 4). Antihypertensive effects of increased
dietary Ca intake have not been fully understood. In this
study, we evaluated the effects of Ca supplementation on
blood pressure and the levels of PRA, PTH, SCa, SP in
DOC–salt treated rats.
Material and Methods
All studies were carried out in male wistar rats with
documented normotension. The experiments adhered to

compared to control and group III (Control vs
group II p=0.014, control vs group IV
p=0.006, group III vs group IV p=0.01).
However, the decrease in PRA was more
important in group IV than group III. Left
heart weight was greater in group IV than
group II (p = 0.033) while right heart weight
was not different among the groups. Kidney
weight showed an increase in group II and
group III, when compared with controls
(p=0.009, p=0.045 respectively).
As a result, at uninephrectomized DOC–salt
treated hypertension model in rats, the
increase in BP was less prominent in Ca
supplemented diet and this effect continued
during the study period. In this hypertension
model with suppressed PRA, we can state
that a decrease in PTH which suggests the
suppression of parathyroid gland, may affect
BP.
Key Words:
parathormon.

Calcium,

hypertension,

legal standards and protocol was approved in advance by
the appropriate committee at TIBDAM, Adana, Turkey.
The rats (130–140 g) were purchased from TIBDAM and
received standart laboratory rat chow (containing 0.5%
NaCl and 22% protein) and tap water ad libitum. The
animals were housed in a humidity and temperature
controlled room with a 12 hour light–dark cycle. One
week after receiving the animals, systolic blood pressure
was recorded by tail plethysmography (rat tail BP
monitor, Harvard Apparatus Ltd., Kent, England) in
conscious state. This was repeated at weekly intervals
until reached 210–260 g body weight. Rats (210–260 g)
were anaesthetized with ketamine (130 mg/kg body
weight {bw} im.) and chlorpromazine (1.3 mg/kg bw im).
Through a midline abdominal incision the right kidney
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was removed. One week after nephrectomy, the rats
were divided into 4 groups; group I; control group (6
rats) which were injected olive oil subcutaneously and
given tap water. Other three groups were injected DOC
dissolved in olive oil (12.5 mg at first and then 6.5 mg
weekly for 6 weeks). Ten miligrams of DOC was dissolved
in 0.4 ml olive oil). DOC injected rats were given 1% NaCl
as drinking water. In Group II (DOC hypertensive group).
8 rats were given normal rat chow containing 1% Ca.
Diet supplemented 2 and 4% CaCl2 were given to 8 rats
and 7 rats, respectively, in group III (DOC–low Ca group)
and group IV (DOC–high Ca group).

Bonferroni was used. The p value less than 0.05 was
assumed to be significant. All results were expressed as
mean and standard deviations.
Results
In uninephrectomized DOCA salt treated rats, increase
in BP is shown in Figure 1. The increase in BP was less
prominent in group IV during the study period. Body
weight increased at the end of follow up period. However,
the increase in body weight in group IV was lower than
other groups (Table). Final day measurements of serum
Ca, P, PTH, PRA and urine Ca, Na, K and comparison of
the groups are shown in Table. There was negative
correlation between serum Ca and P (p=0.001). There
was no correlation between PRA, AII, PTH and urine Ca
and pulse, final weight, serum Ca, P, PRA, PTH, urine Ca
in all rats and within each group.

SBP were measured daily with tail cuff method except
DOC injection days. Rats were followed up 6 weeks. At
the end of the study, blood and urine samples were taken
for serum Ca, P, AII, PTH, PRA, urinary Ca, Na, K.
Repeated measures of analysis of variance technique
was used for between and within group. To determine
the group(s) that are different than other (s),
simultaneous multiple comparison techniques of

During the study period, the changes of body weight
and PRA and PTH levels are shown in Figure 2 and 3.
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Effect of DOC and dietary–calcium on indirect systolic blood pressures in unineprectomized rats. C: Control (n=6), DH: DOC + standard
diet (n=8), DLC: DOC + Low calcium diet (n=8), DHC: DOC + High calcium diet (n=7). Values are mean + SEM. *P<0.05 vs the
prenephrectomy values.
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Table.

The Characteristics of the Rats, and Serum and Urine Levels of Some Biochemical Parameters.

Group I
Control

Group II
Doc–
hypertension

Group III
Doc
Low–Ca

Group IV
Doc
High–Ca

6
225.83±4.91

8
228.12±9.23

8
240.00±16.03

7
226.42±12.15

305.83±16.89

306.25±14.07

326.25±17.67

270.00±19.14

Righ heart
weight (mg)
Left heart
weight (mg)
Kidney
weight (mg)
Pulse (basal)
Pulse (final)
ISBP (basal)
mmHg
ISBP (final)
mmHg
SCa mg/dl
SP mg/dl
PTH ng/ml
PRA ng/ml

149.16±34.70

150.50±24.40

149.37±20.04

142.05±13.80

0.4b, 0.004e,
0.01c, 0.001f,
0.02d
> 0.05

533.83±30.98

557.25±27.97

562.75±49.83

567.1±28.11

0.03e

1191.7±91.1

1385.0±130.2

1395.0±103.4

1304.3±112.7

425.0±35.07
425.00±12.24
128.83±10.77

435.0±27.77
427.50±21.21
129.37±9.79

427.50±31.05
431.25±7.89
130.62±6.23

424.28±32.07
420.00±24.49
130.85±7.88

0.009a
0.0045b
> 0.05
> 0.05
> 0.05a,b,c,d,e

135.83±13.93

166.87±8.42

157.87±10.23

144.28±9.32

10.16±0.50
6.31±1.19
42.53±37.16
14.89±9.59

9.70±0.41
5.92±1.21
42.33±33.18
6.23±3.77

10.88±0.99
6.95±1.53
28.61±28.74
9.00±3.21

10.05±0.57
5.77±1.03
15.71±15.63
3.88±3.44

AII
Urine Na
mEq/L
Urine K
Urine Ca

122.48±162.1
–

222.23±146.0
–

70.16±136.03
320.00±56.56

428.34±531.7
209.00±128.2

> 0.05

81.50±12.02
34.13±10.43

71.50±3.53
39.75±15.93

62.50±30.67
34.40±10.83

72.33±30.42
33.484.44

> 0.05
> 0.05

Number
Body weight
basal (g)
Body weight
final (g)

a
b
c
d
e
f

:
:
:
:
:
:

Control vs group II
Control vs group III
Control vs group IV
Group II vs group III
Group II vs group IV
Group III vs group IV

ISBP :
SCa :
SP :
PRA :
AII :

P value

0.006d
> 0.05
> 0.05
0.014a, 0.01f
0.09b, 0.006c

Indirect systolic blood pressure
Serum calcium
Serum phosphorus
Plasma renin activity
Angiotensin II

Discussion
The effect of Ca supplemented diet on blood pressure
was evaluated in uninephrectomized DOC–salt treated
rats. Blood pressure was markedly attenuated in the rats
on Ca supplemented diet. Ca supplemantation had
long–term antihypertensive effect during the study
period. Serum Ca level did not rise in these rats, especially

in high–Ca diet group. Serum PTH level was not different
significantly between these groups but the level of PTH
decreased on high Ca diet. In salt sensitive low renin
hypertension, there are some paradoxical features (5).
Such hypertensive individuals are often beneficially
responsive both to a Ca antagonist (6) and to high Ca diet
(7). These observations are rather paradoxical. In
addition many such individuals have a higher circulating
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Figure 2.

Effect of DOC and
dietary–calcium
on
body
weight
in
u n i n e p h re c t o m i z e d
rats. C: Control (n=6),
DH: DOC + standard
diet (n=8), DLC: DOC +
Low calcium diet
(n=8), DHC: DOC +
High calcium diet
(n=7). Values are mean
± SD.* P<0.05 vs C.

0

PTH level (8). In our study, in addition to decreased blood
pressure, high Ca diet caused lower serum PTH. If
parathyroid hypertensive factor (PHF) is the major
contributing or causative factor of low–renin
salt–sensitive hypertension, it should be able to elicit this
paradoxical observations. The parathyroid gland is one of
the few glands which are stimulated by a negative calcium
balance in the human body. Therefore, high dietary–Ca
should inhibit the parathyroid gland function and the
production of PHF, hence alleviating hypertension (9).
Some authors showed that a high Ca diet reduced the
blood pressure and PHF in hypertensive patients (5). In
other studies, a high–Ca diet reduced blood pressure and
PHF level in spontanous hypertansive rats compared with
those in animals fed a low–Ca diet (9). Since the
parathyroid gland is stimulated by low–Ca, it is
understandable that hypocalcemia can lead to the
increased activity of the parathyroid gland producing PHF
as well as PTH. The effect of PHF can explain the rather
paradoxical features of low renin salt–sensitive
hypertension. In group IV, the lowest PRA was found.
Group II was not different significantly from group IV for
PRA but control group was different from group II and IV
with regard to PRA. In rats on low–Ca diet, PRA was
decreased, however PRA was not different between other
groups except group IV. The similarities in decreases of
PRA in group IV and II were interesting. In
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mineralocorticoid salt sensitive hypertensive rats, Ca
supplementation for 8 weeks attenuated the increase in
blood pressure and cardiac hypertrophy and prevented
DOC–salt induced sodium volume retention (10). But we
did not find a decrease in left ventricular weight in rats
that were fed with calcium supplemented diet. This
finding was paradoxical with the measurement of blood
pressure, PRA and PTH. As in our study, in hypertensive
men on Ca supplemented diet; serum ionized Ca did not
change but PTH decreased (11).
AII levels were widely variable. Aldosteron levels were
not measured. Excretions of urinary Na, K and Ca were
not changed with high–Ca diet or low–Ca diet. We did not
find any correlation between body weight and blood
pressure in each group and all rats. Increase in body
weight in rats that were fed with high Ca diet was less
than other groups.
As a result, in uninephrectomized DOC –salt
hypertension, Ca supplemented diet (4% more
prominent) attenuated the increase in blood pressure and
this effect continued throughout the study. In the rats on
4% Ca diet, PRA was importantly supressed. However,
body weight in this group did not increase as much as in
others. PTH levels also decreased in group IV, but the
difference was not significant , statistically. Attenuation of
increase in blood pressure may be due to suppression of
parathyroid gland.
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Figure 3.
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C: Control (n=6), DH:
DOC + standard diet
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